Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
0.9060
-0.0414 (-4.37%)
Mar 6, 2026, 4:00 PM EST - Market closed
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $759.94 thousand as of March 6, 2026. Its market cap has decreased by -73.57% in one year.
Market Cap
759.94K
Enterprise Value
-4.08M
1-Year Change
-73.57%
Ranking
Category
Stock Price
$0.91
Market Cap Chart
Since October 28, 2016, Biodexa Pharmaceuticals's market cap has decreased from $55.80M to $759.94K, a decrease of -98.64%. That is a compound annual growth rate of -36.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 794.67K | -58.26% |
| Dec 31, 2025 | 1.90M | -19.06% |
| Dec 31, 2024 | 2.35M | -66.49% |
| Dec 29, 2023 | 7.02M | 64.98% |
| Dec 30, 2022 | 4.26M | -67.32% |
| Dec 31, 2021 | 13.02M | -43.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 2.40M |
| Lyra Therapeutics | 2.27M |
| Bone Biologics | 2.19M |
| Clearmind Medicine | 2.05M |
| Adial Pharmaceuticals | 2.01M |
| Ensysce Biosciences | 1.99M |
| CDT Equity | 1.94M |
| CNS Pharmaceuticals | 1.82M |